Shares of Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM), an up-and-coming biotech stock with a tiny float,…
Read More »Biotech
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced that its licensee, Celly Nutrition, the company behind unbuzzd™, the…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced today the completion of its double-blind, randomized, placebo-controlled crossover…
Read More »
Radiation therapy is a cornerstone of cancer treatment, with approximately 50% of cancer patients undergoing it during their illness. A…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH), a discovery and development-stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is redefining how we recover from alcohol consumption with its revolutionary product,…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) announced it was approved to dual list its shares on the Upstream…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) announced that the company has purchased USD $1 million worth of Bitcoin…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91), a small biopharmaceutical company with an $8 million market cap, has launched…
Read More »
The multiple sclerosis (MS) treatment market, valued at over $20 billion annually, is experiencing a transformative phase. With no definitive…
Read More »